Human Genome Epidemiology Literature Finder
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Lung Neoplasms and ARID1A[original query] |
|---|
| Genetic variants in chromatin-remodeling pathway associated with lung cancer risk in a Chinese population. Gene 2016 May . Geng Liguo, Zhu Meng, Wang Yuzhuo, Cheng Yang, Liu Jia, Shen Wei, Li Zhihua, Zhang Jiahui, Wang Cheng, Jin Guangfu, Ma Hongxia, Shen Hongbing, Hu Zhibin, Dai Junche |
| Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance. Lung cancer (Amsterdam, Netherlands) 2018 Jun 120 113-121. Du Meijun, Thompson Jonathan, Fisher Hannah, Zhang Peng, Huang Chiang-Ching, Wang Lia |
| Interaction analysis between germline susceptibility loci and somatic alterations in lung cancer. International journal of cancer 2018 08 143 (4): 878-885. Wang Yuzhuo, Wang Cheng, Zhang Jiahui, Zhu Meng, Zhang Xu, Li Zhihua, Dai Juncheng, Ma Hongxia, Hu Zhibin, Jin Guangfu, Shen Hongbi |
| Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
| SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Apr . Alessi Joao V, Ricciuti Biagio, Spurr Liam F, Gupta Hersh, Li Yvonne Y, Glass Carolyn, Nishino Mizuki, Cherniack Andrew D, Lindsay James, Sharma Bijaya, Felt Kristen D, Rodig Scott J, Cheng Michael L, Sholl Lynette M, Awad Mark |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sönke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
| Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
| Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer 2022 Sep . Chang Geyun, Li Weihua, Bai Hua, Duan Jianchun, Wang Zhijie, Du Xinyang, Yu Ruofei, Wang Yaxi, Wang Minghao, Zhu Yixiang, Zhang Xue, Li Li, Wan Rui, Wang J |
| Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer. Translational cancer research 2022 May 11 (5): 1245-1254. Zhang Meichun, Wu Jing, Zhong Weinong, Zhao Ziwen, Guo Weiho |
| Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. Therapeutic advances in medical oncology 2022 12 14 17588359221141761. Lee Jii Bum, Park Hyung Soon, Choi Su Jin, Heo Seong Gu, An Ho Jung, Kim Hye Ryun, Hong Min Hee, Lim Sun Min, Chang Kyle, Quinn Katie, Odegaard Justin, Shim Byoung Yong, Cho Byoung Ch |
| SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases. Cancer cell international 2022 11 22 (1): 347. Li Yue, Yang Xinhua, Zhu Weijie, Xu Yuxia, Ma Jiangjun, He Caiyun, Wang Fa |
| Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
| The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
| ARID1A mutations in lung cancer: biology, prognostic role, and therapeutic implications. Trends in molecular medicine 2023 5 . Fukang Jin, Zhiguang Yang, Jingbo Shao, Jianxin Tao, Christoph Reißfelder, Sonja Loges, Lei Zhu, Sebastian Schöl |
| Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing. Medical oncology (Northwood, London, England) 2023 11 40 (12): 349. Shaowen Zhang, Ping Dong, Zongwei Pan, Qian Chen, Junqi Zhu, Zhangfan M |
| Serial Cell-Free DNA Sequencing in ROS1 Fusion-Positive Lung Cancers During Treatment With Entrectinib. JCO precision oncology 2024 6 8 e2300721. Noura J Choudhury, Hyung Jun Woo, Monica Chen, Ronak Shah, Mark Donoghue, Michael Berger, Alexander Dril |
| Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Frontiers in endocrinology 2024 10 15 1364021. Ariel R Choi, Ralph B D'Agostino, Michael K Farris, Mohammed Abdulhaleem, John C Hunting, Yuezhu Wang, Margaret R Smith, Jimmy Ruiz, Thomas W Lycan, W Jeffrey Petty, Christina K Cramer, Stephen B Tatter, Adrian W Laxton, Jaclyn J White, Wencheng Li, Jing Su, Christopher Whitlow, Fei Xing, Michael D Ch |
- Page last reviewed:Feb 1, 2024
- Content source: